Quantcast

Latest Non-steroidal anti-inflammatory drugs Stories

2014-09-22 08:22:36

DUBLIN, Sept. 22, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global and Chinese Diclofenac Industry Report 2014" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 The Global and Chinese Diclofenac Industry Report 2014 is a professional and in-depth study on the current state of the global diclofenac industry with a focus on the Chinese situation. The report provides a basic overview of the industry including definitions,...

2014-09-12 16:23:36

DUBLIN, Sept. 12, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Diclofenac Industry Report 2014" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 The Global Diclofenac Industry Report 2014 is a professional and in-depth study on the current state of the global diclofenac industry . The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The...

2014-09-10 23:02:27

ReportsnReports.com adds “2014 Market Research Report on Global Diclofenac Industry” and “2014 Deep Research Report on Global and China DL-Mandelic Acid Industry” report to its store. Dallas, TX (PRWEB) September 10, 2014 2014 Market Research Report on Global Diclofenac Industry is a professional and in-depth study on the current state of the Diclofenac industry in Global and China. The report provides a basic overview of the industry, including definitions, applications and...

2014-09-08 08:29:52

MISSISSAUGA, ON, Sept. 8, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced that it has reached a full settlement with Mallinckrodt Inc. of Nuvo's claims and Mallinckrodt's counterclaim relating to Nuvo's license to Mallinckrodt of the right to market and sell Pennsaid(®) and Pennsaid 2% in the United States. Under the terms of the settlement agreement, Mallinckrodt will return...

2014-09-05 23:05:16

Researchers in Australia say aspirin may temporarily stave off mesothelioma in asbestos-exposed mice, but will not keep the disease from developing. Raleigh, NC (PRWEB) September 05, 2014 Scientists at the University of Western Australia have found that non-steroidal anti-inflammatory drugs like aspirin and COX-2 inhibitor pain relievers like Celebrex do not appear to prevent mesothelioma, as they had hoped. Surviving Mesothelioma has just posted an article on the research. Click here to...

2014-09-05 16:23:02

NEWARK, Calif., Sept. 5, 2014 /PRNewswire/ -- Depomed, Inc. (Nasdaq:DEPO) today announced that Judge Kentaji Brown Jackson of the federal district court for the District of Columbia has granted Depomed's motion for summary judgment in the company's lawsuit against the United States Food and Drug Administration seeking an order requiring the FDA to grant Gralise(®) (gabapentin) Orphan Drug exclusivity for the management of postherpetic neuralgia (PHN). The court's ruling requires...

fever origins
2014-08-28 03:00:29

David Engblom, Linköping University Fever is a response to inflammation, and is triggered by an onset of the signaling substance prostaglandin. Researchers at Linköping University can now see precisely where these substances are produced – a discovery that paves the way for smarter drugs. When you take an aspirin, all production of prostaglandins in the body is suppressed. All symptoms of inflammation are eased simultaneously, including fever, pain and loss of appetite. But it might...

2014-08-25 16:27:20

NEWARK, Calif., Aug. 25, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) today announced that it will be presenting at the Morgan Stanley 2014 Global Healthcare Conference in New York City. The presentation at the Morgan Stanley conference is scheduled for 2:40 pm ET (11:40 am PT) on Wednesday September 10, 2014. The presentation will be webcast, and the webcast can be accessed via the Investor Relations page of the Depomed website at www.depomed.com. A recording of the webcast...

2014-08-25 08:27:26

New Indication in Chronic Pain Marks Company's Third FDA Approval in Less Than a Year PHILADELPHIA, Aug. 25, 2014 /PRNewswire/ -- Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today the United States Food and Drug Administration (FDA) has approved ZORVOLEX® (diclofenac) capsules, a nonsteroidal anti-inflammatory drug (NSAID), for the management of osteoarthritis pain. This marks the second indication...

NSAIDs may slow breast cancer recurrence
2014-08-15 04:51:37

redOrbit Staff & Wire Reports - Your Universe Online Over-the-counter anti-inflammatory drugs such as aspirin or ibuprofen could significantly lower breast cancer recurrence rates in overweight or obese women, according to new research appearing in Friday’s edition of the journal Cancer Research. In the study, Dr. Andrew Brenner of the Cancer Therapy & Research Center (CRTC) at the University of Texas Health Science Center at San Antonio and his colleagues found that women...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related